Study of hydatidiform mole in China
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at people diagnosed with a hydatidiform mole (a rare pregnancy-related tumor) to understand how it progresses. It follows your health after the mole is removed and checks your hCG levels (a pregnancy hormone) to see if you develop a related condition called post-molar gestational trophoblastic neoplasia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a hydatidiform mole (confirmed by a doctor or tissue test).
- Your complete medical records are available, including lab and pathology reports.
- There is no sign that the mole has grown into the muscle of the uterus or spread to other parts of the body.
- Your hCG levels returned to normal after the mole was removed and you were followed for at least 6 months, or you were diagnosed with postmolar gestational trophoblastic neoplasia during follow-up.
- You do not have a history of serious mental illness, infectious diseases, or immune system disorders (like lupus, myasthenia gravis, or HIV).
- You are willing to join the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people diagnosed with a hydatidiform mole, a rare type of pregnancy growth, to better understand how it progresses and what treatments work best. By participating, you can help improve care for others with this condition.
This study looks at different treatment approaches for hydatidiform mole when a CT scan shows lung nodules and the team cannot rule out spread. It may help guide the safest next steps and follow-up plan.
This study is for people who have a pregnancy-related tumor called gestational trophoblastic disease. It looks at this condition in patients who were diagnosed by blood test (hCG) changes or tissue testing, to better understand and manage the disease.
This study uses ultrasound to check blood flow in the artery that supplies the uterus. The goal is to see if certain measurements can predict whether a complete hydatidiform mole might turn into a more serious condition that needs more treatment.
This trial is creating a database for women diagnosed with gestational trophoblastic neoplasia (GTN), which includes tumors that can develop after a molar pregnancy or other pregnancy-related conditions. By joining, you help researchers better understand and improve treatment for these rare tumors.
This trial tests whether using a hysteroscope (a tiny camera) to gently scrape the uterus again, instead of starting chemotherapy right away, can effectively treat a low-risk, pregnancy-related tumor that returns after a molar pregnancy. It's for Chinese women whose disease is still in an early, low-risk stage.
Hear when a new Hydatidiform Mole trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.